Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use

Clinical Infectious Diseases

Volumn 23, Issue SUPPL. 1, 1996, Pages

  Ho, Macy ^b   Yang, Debbie ^b   Wyle, Frederic A ^b   Mulligan, Maury Ellis ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFRADINE; CEFTAZIDIME; CEFTIZOXIME; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; PIPERACILLIN; TIMENTIN; VANCOMYCIN;

ANAEROBIC INFECTION; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; DIARRHEA; DISEASE PREDISPOSITION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL;

EID: 0029828270     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.supplement_1.s102     Document Type: Article

References (10)

1. Siegel DL, Edelstein PH, Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA 1990;263:979-82.
2. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
3. de Lalla F, Privitera G, Ortisi G, et al. Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital. J. Antimicrob Chemother 1989;23:623-31.
4. Nelson DE, Auerbach SB, Baltch AL, et al. Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins. Infect Control Hosp Epidemiol 1994;15:88-94.
5. Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994;120:272-7.
6. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459-77.
7. Mulligan ME, Peterson LR, Kwok RY, Clabots CR, Gerding DN. Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 1988;26:41-6.
8. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
9. Struelens MJ, Maas A, Nonhoff C, et al. Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. Am J Med 1991;91(suppl 3B):138S-44S.
10. Gordin F, Gibert C, Schmidt ME. Clostridium difficile colitis associated with trimethoprim-sulfamethoxazole given as prophylaxis for Pneumocystis carinii pneumonia. Am J Med 1994;96:94-5.